These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35429409)
21. Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy. Parkin E; O'Reilly DA; Adam R; Kaiser GM; Laurent C; Elias D; Capussotti L; Renehan AG; Eur J Surg Oncol; 2014 Nov; 40(11):1436-44. PubMed ID: 25189474 [TBL] [Abstract][Full Text] [Related]
22. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS]. Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159 [TBL] [Abstract][Full Text] [Related]
23. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases]. Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977 [TBL] [Abstract][Full Text] [Related]
25. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? Lubezky N; Geva R; Shmueli E; Nakache R; Klausner JM; Figer A; Ben-Haim M World J Surg; 2009 May; 33(5):1028-34. PubMed ID: 19234865 [TBL] [Abstract][Full Text] [Related]
26. Impact of preoperative and postoperative FOLFOX chemotherapies in patients with resectable colorectal liver metastasis. Faron M; Chirica M; Tranchard H; Balladur P; de Gramont A; Afchain P; Andre T; Paye F J Gastrointest Cancer; 2014 Sep; 45(3):298-306. PubMed ID: 24610400 [TBL] [Abstract][Full Text] [Related]
27. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases? Reddy SK; Tsung A; Marsh JW; Geller DA J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519 [TBL] [Abstract][Full Text] [Related]
28. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score. Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis. Nakanishi M; Kuriu Y; Murayama Y; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Otsuji E Hepatogastroenterology; 2014 Sep; 61(134):1582-7. PubMed ID: 25436346 [TBL] [Abstract][Full Text] [Related]
30. Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease? Kataoka K; Kanazawa A; Iwamoto S; Kato T; Nakajima A; Arimoto A World J Surg; 2014 Apr; 38(4):936-46. PubMed ID: 24166026 [TBL] [Abstract][Full Text] [Related]
31. The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis. Kawaguchi Y; Vauthey JN Ann Surg Oncol; 2020 Oct; 27(11):4263-4270. PubMed ID: 32803551 [TBL] [Abstract][Full Text] [Related]
32. Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC). Valenzuela CD; Moaven O; Gawdi R; Stauffer JA; Del Piccolo NR; Cheung TT; Corvera CU; Wisneski AD; Cha C; Pourhabibi Zarandi N; Dourado J; Perry KC; Russell G; Shen P J Surg Oncol; 2022 Dec; 126(7):1242-1252. PubMed ID: 35969175 [TBL] [Abstract][Full Text] [Related]
33. Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study. Hoogteijling TJ; Abu Hilal M; Zimmitti G; Aghayan DL; Wu AGR; Cipriani F; Gruttadauria S; Scatton O; Long TCD; Herman P; Marino MV; Mazzaferro V; Chiow AKH; Sucandy I; Ivanecz A; Choi SH; Lee JH; Gastaca M; Vivarelli M; Giuliante F; Ruzzenente A; Yong CC; Yin M; Fondevila C; Efanov M; Morise Z; Di Benedetto F; Brustia R; Dalla Valle R; Boggi U; Geller D; Belli A; Memeo R; Mejia A; Park JO; Rotellar F; Choi GH; Robles-Campos R; Wang X; Sutcliffe RP; Pratschke J; Tang CN; Chong CCN; D'Hondt M; Monden K; Lopez-Ben S; Kingham TP; Ferrero A; Ettorre GM; Cherqui D; Liang X; Soubrane O; Wakabayashi G; Troisi RI; Han HS; Cheung TT; Sugioka A; Dokmak S; Chen KH; Liu R; Fuks D; Zhang W; Aldrighetti L; Edwin B; Goh BKP; Eur J Surg Oncol; 2024 Jun; 50(6):108309. PubMed ID: 38626588 [TBL] [Abstract][Full Text] [Related]
34. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases. Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952 [TBL] [Abstract][Full Text] [Related]
35. Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer. Julio C; Benoist S; Allard MA; Navarro F; Pessaux P; Sa Cunha A; Brouquet A; J Surg Oncol; 2022 Aug; 126(2):330-338. PubMed ID: 35397122 [TBL] [Abstract][Full Text] [Related]
36. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer? Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329 [TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study. Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190 [TBL] [Abstract][Full Text] [Related]
39. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases. Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708 [TBL] [Abstract][Full Text] [Related]
40. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first. Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]